Mots-C 40mg

Mots-C is a cyclic arginine-glycine-aspartate (RGD)-based peptide synthesized for experimental analysis in academic and industrial research settings. This compound is intended for use in laboratory studies to investigate mechanisms related to cell adhesion, migration, and integrin-mediated signaling pathways.

Research Context

The peptide Mots-C is part of a broader class of synthetic analogs derived from integrin-binding sequences. Research utilizing similar peptides has explored their potential in studying cell-cell interactions, tumor metastasis, and vascular biology. Due to its structural rigidity, Mots-C offers advantages in maintaining precise binding affinities in controlled experimental conditions.

Research Overview

Mots-C is primarily utilized in vitro studies, where its effects on integrin-mediated signaling can be isolated and quantified. Investigations may include examining competitive binding, conformational changes, and downstream signaling cascades in cells expressing relevant integrin receptors. While not clinically validated for therapeutic applications, its structural properties make it a valuable tool in mechanistic research.

Key Research Focus Areas

• Cell adhesion studies to assess integrin binding specificity
• Investigations into integrin-mediated signaling pathways
• Analysis of competitive binding interactions with natural ligands
• Mechanistic studies of peptide-mediated cell migration
• Biophysical characterization of integrin-peptide interactions

Safety and Compliance

This peptide is supplied for research purposes only and must be handled according to institutional guidelines for hazardous materials. Researchers are advised to employ appropriate safety protocols including proper labeling, storage under controlled conditions, and disposal procedures in compliance with regulatory standards for laboratory waste.

For research use only. Not for human or animal consumption.